quantisnow
FeedTopReportsPricing
⌘K
Live feed
03:30:00·226d
PRRelease
Immunocore Holdings plc logo
Alexion Pharmaceuticals, Inc. logo

Resolution Therapeutics appoints Lucy Singah as Chief Financial Officer and Daniel Kennedy as Chief Business Officer

IMCR· Immunocore Holdings plcALXN· Alexion Pharmaceuticals, Inc.
Health Care
Original source

Companies

  • IMCR
    Immunocore Holdings plc
    Health Care
  • ALXN
    Alexion Pharmaceuticals, Inc.
    Health Care

Recent analyst ratings

  • Mar 16IMCRUpdateJefferies$33.00
  • Jan 7IMCRUpdateUBS$55.00
  • Oct 31IMCRUpdateWells Fargo$60.00
  • Sep 18IMCRUpdateGuggenheim-
  • Aug 25IMCRUpdateJefferies$48.00
  • May 27IMCRUpdateDeutsche Bank$65.00

Related

  • PR4d
    KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
  • SEC7d
    SEC Form DEF 14A filed by Immunocore Holdings plc
  • PR18d
    Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
  • PR37d
    Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting
  • ANALYST39d
    Immunocore downgraded by Jefferies with a new price target
  • SEC48d
    Amendment: SEC Form SCHEDULE 13G/A filed by Immunocore Holdings plc
  • PR49d
    Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types
  • PR52d
    Immunocore to present at upcoming investor conferences
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022